When was PsychoGenics founded?

PsychoGenics was founded in 1999 and raised its 1st funding round 8 years after it was founded.

Where is PsychoGenics located?

PsychoGenics is headquartered in Tarrytown, United States. It is registered at Paramus, New Jersey.

How many employees does PsychoGenics have?

As of Dec 31, 2020, PsychoGenics has 124 employees, reflecting a 21% year-over-year growth in headcount.

Is PsychoGenics a funded company?

PsychoGenics is a funded company, having raised an undisclosed amount across 6 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Dec 27, 2007.

When was the latest funding round of PsychoGenics?

PsychoGenics' latest funding was a $***** Grant (prize money) round on Aug 28, 2024, with participation from 1 investor. Its primary sector is Biopharma Outsourcing. In United States, the Biopharma Outsourcing sector has seen $260M in funding in 2026 to date.

Where does PsychoGenics rank among its competitors?

PsychoGenics ranks 6th amongst 114 active competitors, of which 10 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Mirimus, which secured $350K in Sep, 2024.

Who are the top competitors of PsychoGenics?

PsychoGenics' top competitors include TransCure bioServices, GenOway and Alpha Genesis. Among them, Mirimus secured the most recent funding round in September, 2024.

PsychoGenics - 2026 Company Profile, Funding & Competitors

Company Details

Psychogenics offers drug discovery capabilities for companies focusing on CNS and orphan disorders psychiatric and neurodegenerative disorders, pain and inflammation, spinal cord and traumatic brain injury. PsychoGenics' capabilities include behavioral testing, electrophysiology, molecular biology, microdialysis and a variety of in-licensed transgenic mouse models. PsychoGenics’ technologies have been developed to facilitate high throughput, in vivo, compound screening. It facilitates drug discovery by combining expertise in behavioral neurobiology, bioinformatics and behavioral testing platforms, that can rapidly screen compound libraries for CNS activity.

Website: psychogenics.com
Email ID: *****@psychogenics.com
Registered Address: Paramus, New Jersey

Key Metrics

Founded Year

1999

Location

Tarrytown, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Aug 28, 2024, $*****

Investors

NIH & 1 more

Ranked

6^th among 114 active competitors

Employee Count

124 as on Dec 31, 2020

Investment & Acquisitions

Resilience Therapeutics

Similar Companies

TransCure bioServices & 129 more

View PsychoGenics' full profile

PsychoGenics is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Psychogenics Inc. CIN: 4154628 , United States, Active	Oct 18, 2011	-	-	-
PSYCHOGENICS INC. CIN: 141989159 , United States, Active	Dec 26, 999	-	124 (As on Dec 31, 2020)	-

PsychoGenics has raised funding over 6 rounds. Its first funding round was on Dec 27, 2007. Its latest funding round was a Grant (prize money) round on Aug 28, 2024 for $*****. 1 investor participated in its latest round. PsychoGenics has 2 institutional investors.

Here is the list of recent funding rounds of PsychoGenics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 28, 2024	6765333	Grant (prize money)	7477847	6615770	7996856	6282469
Aug 05, 2024	2702927	Grant (prize money)	1680160	8317772	6271847	HHS
Aug 15, 2023	6448573	Grant (prize money)	1329063	2391637	4128038	HHS

Access funding benchmarks and valuations. Sign up today!

View details of PsychoGenics's funding rounds and investors

PsychoGenics' employee count trend

PsychoGenics has 124 employees as of Dec 20. The total employee count is 20.0% more than what it was in Dec 19. Here is PsychoGenics's employee count trend over the years:

Uncover PsychoGenics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PsychoGenics include TransCure bioServices, GenOway and Alpha Genesis. Here is the list of Top 10 competitors of PsychoGenics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TransCure bioServices 2012, Archamps (France), Series B	Developer of humanized animal models for preclinical studies	$3.58M	Financiere Arbevel, Savoie Mont Blanc Angels ... & 5 others	59/100
2nd	GenOway 1999, Lyon (France), Public	Provider of transgenic rodent models and customized cell lines for preclinical development	$11.6M	Eurostars, Innovation Capital & 6 others	58/100
3rd	Alpha Genesis 2003, Yemassee (United States), Series B	Preclinical research services specializing in nonhuman primate models for therapy development	$12.5M	-	50/100
4th	InVivo Biosystems 2019, Eugene (United States), Series A	Provider of animal models for in-vivo analytical services	$8.16M	Rogue Venture Partners, Launch Oregon & 5 others	46/100
5th	Explora BioLabs 2004, San Diego (United States), Acquired	Provider of discovery pharmacology and vivarium services for biotechnology and pharmaceutical clients	-	Aspect Investors, Milk Street Ventures & 1 others	42/100
6th	PsychoGenics 1999, Tarrytown (United States), Funding Raised	Preclinical CRO with specific focus on CNS and orphan disorders.	-	NIH, HHS	41/100
7th	Bolder Biopath 2003, Boulder (United States), Acquired	Preclinical research services: pharmacology, toxicology, pathology, bioanalysis, and research models	-	-	38/100
8th	Neurofit 1996, Illkirch Graffenstaden (France), Acquired	Animal models of neurological and psychiatric disorders for drug discovery	-	-	38/100
9th	Mirimus 2011, Cold Spring Harbor (United States), Series A	Accelerating drug discovery with precision preclinical services and innovative disease models	$2M	Design Technologies, Topspin Consumer Partners ... & 1 others	37/100
10th	Noble Life Sciences 2010, Woodbine (United States), Seed	Preclinical contract research organization offering standard GLP and non-GLP services	$335K	1776, TEDCO & 3 others	37/100